Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative LRMR - Larimar Therapeutics, Inc.
14.1 M
LAST VALUE
8.04%
2 YEAR CAGR
1.73%
5 YEAR CAGR
12.85%
10 YEAR CAGR